AbbVie Inc. (BVMF:ABBV34)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of BRL 2.18 trillion. The enterprise value is 2.52 trillion.

Market Cap	2.18T
Enterprise Value	2.52T

Important Dates

The next estimated earnings date is Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Oct 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	73.86%
Float	1.76B

Valuation Ratios

The trailing PE ratio is 174.45 and the forward PE ratio is 17.04.

PE Ratio	174.45
Forward PE	17.04
PS Ratio	6.87
PB Ratio	-157.60
P/TBV Ratio	n/a
P/FCF Ratio	20.81
P/OCF Ratio	19.64
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.92, with an EV/FCF ratio of 24.00.

EV / Earnings	201.21
EV / Sales	7.97
EV / EBITDA	15.92
EV / EBIT	22.36
EV / FCF	24.00

Financial Position

The company has a current ratio of 0.72

Current Ratio	0.72
Quick Ratio	0.47
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.50
Interest Coverage	7.38

Financial Efficiency

Return on equity (ROE) is 137.96% and return on invested capital (ROIC) is 18.50%.

Return on Equity (ROE)	137.96%
Return on Assets (ROA)	9.59%
Return on Invested Capital (ROIC)	18.50%
Return on Capital Employed (ROCE)	22.50%
Revenue Per Employee	5.78M
Profits Per Employee	227,517
Employee Count	55,000
Asset Turnover	0.43
Inventory Turnover	3.63

Taxes

Income Tax	-3.92B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.06% in the last 52 weeks. The beta is 0.35, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+11.06%
50-Day Moving Average	74.98
200-Day Moving Average	69.93
Relative Strength Index (RSI)	56.49
Average Volume (20 Days)	2,084

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.41

Income Statement

In the last 12 months, AbbVie had revenue of BRL 317.87 billion and earned 12.51 billion in profits. Earnings per share was 7.04.

Revenue	317.87B
Gross Profit	227.15B
Operating Income	113.33B
Pretax Income	8.85B
Net Income	12.51B
EBITDA	157.32B
EBIT	113.33B
Earnings Per Share (EPS)	7.04

Balance Sheet

The company has 30.22 billion in cash and 366.92 billion in debt, giving a net cash position of -336.70 billion.

Cash & Cash Equivalents	30.22B
Total Debt	366.92B
Net Cash	-336.70B
Net Cash Per Share	n/a
Equity (Book Value)	-13.85B
Book Value Per Share	-7.97
Working Capital	-57.83B

Cash Flow

In the last 12 months, operating cash flow was 111.17 billion and capital expenditures -6.27 billion, giving a free cash flow of 104.90 billion.

Operating Cash Flow	111.17B
Capital Expenditures	-6.27B
Free Cash Flow	104.90B
FCF Per Share	n/a

Margins

Gross margin is 71.46%, with operating and profit margins of 35.65% and 4.00%.

Gross Margin	71.46%
Operating Margin	35.65%
Pretax Margin	2.78%
Profit Margin	4.00%
EBITDA Margin	49.49%
EBIT Margin	35.65%
FCF Margin	33.00%

Dividends & Yields

This stock pays an annual dividend of 1.54, which amounts to a dividend yield of 2.00%.

Dividend Per Share	1.54
Dividend Yield	2.00%
Dividend Growth (YoY)	10.16%
Years of Dividend Growth	5
Payout Ratio	21.87%
Buyback Yield	-0.01%
Shareholder Yield	2.09%
Earnings Yield	0.57%
FCF Yield	4.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 21, 2022. It was a forward split with a ratio of 16.

Last Split Date	Nov 21, 2022
Split Type	Forward
Split Ratio	16

Scores

AbbVie has an Altman Z-Score of 2.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.21
Piotroski F-Score	7